Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 4Breast Neoplasms 3Uterine Cervical Neoplasms 1Stomach Neoplasms 1Risk Reduction Behavior 1Patient Preference 1Patient Acceptance of Health Care 1Health Behavior 1Esophageal Neoplasms 1Diabetes Mellitus 1Coronary Disease 1Behavior 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

Endoscopy 13Endoscopy, Digestive System 12Radiofrequency Ablation 7Esomeprazole 7Biopsy 7Endoscopic Mucosal Resection 6Specimen Handling 4Proflavine 4Omeprazole 4Aspirin 4Gastroscopy 3YF 476 2Proton Pump Inhibitors 2Photochemotherapy 2Narrow Band Imaging 2Microscopy, Confocal 2Metformin 2Lansoprazole 2Itraconazole 2Endoscopes 2Diagnostic Imaging 2Dexlansoprazole 2Cryotherapy 2Cryosurgery 2Breath Tests 22-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2rofecoxib 1polyphenon E 1plecanatide 1omeprazole, sodium bicarbonate drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Barrett Esophagus × Risk Assessment × Clear all
NCT07206589 2026-04-17

Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial

Mayo Clinic

Phase NA Not yet recruiting
1,010 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡